Related Experiment Video
Updated: Oct 7, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Transcription Factor Activation Profiles (TFAP) identify compounds promoting differentiation of Acute Myeloid
Federica Riccio1, Elisa Micarelli2, Riccardo Secci2
1University of Rome "Tor Vergata", Department of Biology, Rome, Italy. federicariccio1989@libero.it.
Abstract:
Repurposing of drugs for new therapeutic use has received considerable attention for its potential to limit time and cost of drug development. Here we present a new strategy to identify chemicals that are likely to promote a desired phenotype. We used data from the Connectivity Map (CMap) to produce a ranked list of drugs according to their potential to activate transcription factors that mediate myeloid differentiation of leukemic progenitor cells. To validate our strategy, we tested the in vitro differentiation potential of candidate compounds using the HL-60 human cell line as a myeloid differentiation model. Ten out of 22 compounds, which were ranked high in the inferred list, were confirmed to promote significant differentiation of HL-60. These compounds may be considered candidate for differentiation therapy. The method that we have developed is versatile and it can be adapted to different drug repurposing projects.
More Related Videos
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Master Transcription Regulators
Transcription Factors
Differentiation of Common Myeloid Progenitor Cells
General Transcription Factors
RNA Polymerase II Accessory Proteins

